Diagnostic and prognostic potential of new markers for cervical cancer
Hybrid Capture (CH2) evaluation in patients with atypical squamous cells of undete...
Comparison of automated cytological analysis of anal cytology in two different mom...
Full text | |
Author(s): |
Luiz Carlos Zeferino
;
Jamira Machado Ramos Catharino
;
Marco Aurelio Salvino de Araujo
;
Luiz Carlos Borges da Silva
;
Silvia Regina Vedoato
;
Júlia Kawamura Tambascia
;
Edson Zangiacomi Martinez
Total Authors: 7
|
Document type: | Journal article |
Source: | Revista Brasileira de Ginecologia e Obstetrícia; v. 22, n. 3, p. 129-134, 2000-04-00. |
Abstract | |
Purpose: to compare the performance of cervical canal and vaginal cul-de-sac samples for colpocytology testing, in order to diagnose cervical neoplasia. Methods: three sequential groups were constituted: group 1 - 10,048 women with ectocervix and cul-de-sac samples collected with the use of an Ayre spatula; group 2 - 3,847 women with ectocervix, cul-de-sac and cervical canal samples taken with an Ayre spatula and a cytobrush, and group 3 -- 4,059 women with ectocervix and cervical canal samples, using an Ayre spatula and a cytobrush. ANOVA (analysis of variance) and comparison of proportions were utilized for the statistical analysis. Results: the rates of abnormal tests in groups 2 (2.6%) and 3 (2.4%), including all squamous and glandular lesions, were significantly higher than in group 1 (2.0%). The diagnosis rates of low-grade squamous intraepithelial lesion (LGSIL) were not statistically different between the three groups (1.27, 1.25 and 1.07%). On the other hand, the diagnosis rates of high-grade squamous intraepithelial lesion (HGSIL) were statistically higher in groups 2 (0.81%) and 3 (0.77%) than in group 1 (0.54%). The difference between the rates of the second and the third groups did not present any statistical significance. Conclusions: the cervical canal sampling improves the performance of cytologic testing for the diagnosis of HGSIL, while cul-de-sac sampling does not change significantly the performance in diagnosing cervical neoplasia. (AU) |